94 related articles for article (PubMed ID: 12369563)
21. Very late [corrected] thrombosis of a sirolimus-eluting stent.
Henderson D; Gunalingam B
Catheter Cardiovasc Interv; 2006 Sep; 68(3):406-8. PubMed ID: 16892439
[TBL] [Abstract][Full Text] [Related]
22. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
23. The approach to small vessels in the era of drug-eluting stents.
Holmes DR; Kereiakes DJ
Rev Cardiovasc Med; 2005; 6 Suppl 1():S31-7. PubMed ID: 15665796
[TBL] [Abstract][Full Text] [Related]
24. Overview of pharmacology and clinical trials program with the zotarolimus-eluting endeavor stent.
Kandzari DE; Leon MB
J Interv Cardiol; 2006 Oct; 19(5):405-13. PubMed ID: 17020565
[TBL] [Abstract][Full Text] [Related]
25. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS.
Perin EC
Rev Cardiovasc Med; 2005; 6 Suppl 1():S13-21. PubMed ID: 15665793
[TBL] [Abstract][Full Text] [Related]
26. Drug-eluting stents: clinical perspectives on drug and design differences.
Rogers CD
Rev Cardiovasc Med; 2005; 6 Suppl 1():S3-12. PubMed ID: 15665795
[TBL] [Abstract][Full Text] [Related]
27. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation.
Lee SH; Park JS; Shin DG; Kim YJ; Hong GR; Kim W; Shim BS
Am J Cardiol; 2007 Aug; 100(4):627-30. PubMed ID: 17697818
[TBL] [Abstract][Full Text] [Related]
28. Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.
Büllesfeld L; Gerckens U; Müller R; Grube E
Z Kardiol; 2003 Oct; 92(10):825-32. PubMed ID: 14579046
[TBL] [Abstract][Full Text] [Related]
29. Single-digit target vessel revascularization in multivessel coronary interventions with sirolimus-eluting stents: goodbye to coronary bypass grafting.
Colombo A
Catheter Cardiovasc Interv; 2004 Sep; 63(1):61-2. PubMed ID: 15343569
[No Abstract] [Full Text] [Related]
30. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
31. Complex coronary intervention in the drug-eluting stent era. Introduction.
Kereiakes DJ
Rev Cardiovasc Med; 2005; 6 Suppl 1():S1-2. PubMed ID: 15665792
[No Abstract] [Full Text] [Related]
32. Lessons from the E-SIRIUS trial.
Schofer J
Ital Heart J; 2004 Jan; 5(1):1-2. PubMed ID: 15080572
[No Abstract] [Full Text] [Related]
33. Percutaneous interventions in radiation-associated coronary in-stent restenosis.
Wexberg P; Beran G; Lang I; Siostrzonek P; Kirisits C; Glogar D; Gottsauner-Wolf M
Cardiovasc Intervent Radiol; 2003; 26(2):154-7. PubMed ID: 12638038
[TBL] [Abstract][Full Text] [Related]
34. Restenosis treatment in the drug-eluting stent era.
Presbitero P; Boccuzzi G
Ital Heart J; 2005 Jun; 6(6):514-21. PubMed ID: 16008157
[TBL] [Abstract][Full Text] [Related]
35. Polymer coating techniques for drug-eluting stents.
al-Lamee K; Cook D
Med Device Technol; 2003; 14(1):12-4. PubMed ID: 12974119
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
Vijayakumar M; Lemos PA; Hoye A; Ong AT; Aoki J; Granillo GR; McFadden EP; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Cummins PA; Serruys PW
Am J Cardiol; 2004 Oct; 94(7):909-13. PubMed ID: 15464675
[TBL] [Abstract][Full Text] [Related]
37. Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents.
Prasad CK; Resmi KR; Krishnan LK; Vaishnav R
J Biomater Appl; 2005 Apr; 19(4):271-86. PubMed ID: 15788425
[TBL] [Abstract][Full Text] [Related]
38. Drug-eluting stents for the treatment of in-stent restenosis: a clinical review.
Yan BP; Ajani AE; Waksman R
Cardiovasc Revasc Med; 2005; 6(1):38-43. PubMed ID: 16263355
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.
Wessely R; Hausleiter J; Michaelis C; Jaschke B; Vogeser M; Milz S; Behnisch B; Schratzenstaller T; Renke-Gluszko M; Stöver M; Wintermantel E; Kastrati A; Schömig A
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):748-53. PubMed ID: 15681298
[TBL] [Abstract][Full Text] [Related]
40. Drug-eluting stent: the emerging technique for the prevention of restenosis.
Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
